Skip to content

Serratus anterior plane block versus rhomboid intercostal and subserratus block for continuous analgesia in rib fractures

Serratus anterior plane block versus rhomboid intercostal and subserratus block for continuous analgesia in rib fractures

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
PACTR
Registry ID
PACTR202207703483624
Enrollment
50
Registered
2022-07-18
Start date
2022-06-29
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia

Interventions

Serratus anterior plane block for continuous analgesia in rib fractures
Rhomboid intercostal and subserratus block for continuous analgesia in rib fractures

Sponsors

mansoura university emergency hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Adult patients of both gender, aged between 18-60 years with isolated thoracic trauma leading to unilateral multiple rib fractures = 6 ribs and admitted to trauma intensive care unit at Mansoura University Emergency Hospital.

Exclusion criteria

Exclusion criteria: Patients with > 6 rib fractures, bilateral fractures, ?ail chest, intubated and sedated patient, associated intracranial hemorrhage which affects patient’s mental status, trachea, larynx and sternum fractures, polytrauma patients, hypersensitivity to bupivacaine, infection at the site of injection, bleeding disorders, hepatic, cardiac and renal failure and patients with body mass index >35.

Design outcomes

Primary

MeasureTime frame
Change in pain intensity measured by visual analogue score (VAS) after 24 hour of bupivacaine infusion.

Secondary

MeasureTime frame
- Change in pain intensity measured by visual analogue score after 2 hour, 48 hour, 72 hour and every 24 hour till the catheter removed - Intensive care unit (ICU) length of stay (LOS). - Need for respiratory support (non-invasive or invasive mechanical ventilation). - Development of pneumonia or respiratory failure. - Development of complications of the block (pneumothorax, hemothorax and local anesthetic toxicity). - In-hospital mortality. - Total pethidine consumption.

Countries

Egypt

Contacts

Public ContactMarwa Abdo

lecturer

marwabdo@gmail.com00201002477789

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026